Stuart Arbesfeld, M.D.
NPI 1326123308 · Specialist · Lowell, MA
Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Stuart Arbesfeld, M.D. is a Specialist provider in Lowell, MA (NPI 1326123308).
Provider details
- NPI number
- 1326123308
- Entity type
- Individual
- Primary specialty
- SpecialistOther Service Providers
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- No
- License
- 57972 (MA)
Specialties & taxonomies
Other Service Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure28% of score
19 yrs in NPPES registry
- Profile completeness28% of score
100% of core fields populated
- Practice footprint17% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)28% of score
5,432 Medicare services, 2024 (ranked within specialty)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 2,126 | $8 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 1,707 | $99 |
| Destruction of Precancer Skin Growth, 1 Growth17000 | 687 | $71 |
| Biopsy of Related Skin Growth, First Growth11102 | 463 | $113 |
| New Patient Office Or Other Outpatient Visit With Low Level of Medical Decision Making, If Using Time, 30 Minutes Or More99203 | 118 | $122 |
| Destruction of Skin Growth, 1-14 Growths |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 24 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Triamcinolone Acetonide | 366 | 249 |
| Ketoconazole | 257 | 117 |
| Betamethasone/Propylene Glycbrand: Betamethasone Diprop Augmented | 189 | 106 |
| Mupirocin | 119 | 82 |
| Hydrocortisone | 119 | 71 |
| Betamethasone Dipropionate | 109 | 66 |
| Mometasone Furoate | 80 | 43 |
| Cephalexin |
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-10-26
- Last updated
- 2007-07-08
Frequently asked questions
- What is Stuart Arbesfeld's NPI number?
- Stuart Arbesfeld's National Provider Identifier (NPI) is 1326123308, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Stuart Arbesfeld's specialty?
- Stuart Arbesfeld is listed in the NPPES registry with a primary specialty of Specialist (Other Service Providers).
- Where is Stuart Arbesfeld located?
- Stuart Arbesfeld's practice location on file with NPPES is 275 Varnum Ave, Lowell, MA 01854-2141.
- What is Stuart Arbesfeld's phone number?
- The practice phone number listed in the NPPES registry for Stuart Arbesfeld is (978) 452-3888.
- Does Stuart Arbesfeld accept Medicare?
- Stuart Arbesfeld is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Stuart Arbesfeld's NPI active?
- Yes — Stuart Arbesfeld's NPI (1326123308) is active in the NPPES registry as of the last update on 2007-07-08.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.